GB202015585D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- GB202015585D0 GB202015585D0 GBGB2015585.9A GB202015585A GB202015585D0 GB 202015585 D0 GB202015585 D0 GB 202015585D0 GB 202015585 A GB202015585 A GB 202015585A GB 202015585 D0 GB202015585 D0 GB 202015585D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- new compounds
- compounds
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/65392—Five-membered rings containing two nitrogen atoms
- C07F9/65397—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2015585.9A GB202015585D0 (en) | 2020-10-01 | 2020-10-01 | New compounds |
| ES21816508T ES3018732T3 (en) | 2020-10-01 | 2021-09-30 | Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders |
| AU2021352146A AU2021352146A1 (en) | 2020-10-01 | 2021-09-30 | Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders |
| JP2023520459A JP7793614B2 (ja) | 2020-10-01 | 2021-09-30 | チアジアゾロン誘導体と、それらの糖尿病および関連疾患の治療のためのａｍｐｋアゴニストとしての使用 |
| CA3193947A CA3193947A1 (en) | 2020-10-01 | 2021-09-30 | Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders |
| KR1020237014527A KR20230079163A (ko) | 2020-10-01 | 2021-09-30 | 티아다이아졸론 유도체와 당뇨병 및 관련 장애를 치료하기 위한 ampk 작용제로서 그 용도 |
| HUE21816508A HUE071685T2 (hu) | 2020-10-01 | 2021-09-30 | Tiadiazolon-származékok és alkalmazásuk AMPK agonistákként diabétesz és kapcsolódó rendellenességek kezelésében |
| MX2023003825A MX2023003825A (es) | 2020-10-01 | 2021-09-30 | Derivados de tiadiazolona y su uso como agonistas de ampk para el tratamiento de la diabetes y trastornos relacionados. |
| PL21816508.2T PL4222147T3 (pl) | 2020-10-01 | 2021-09-30 | Pochodne tiadiazolonu i ich zastosowanie jako agonistów ampk w leczeniu cukrzycy i powiązanych z nią zaburzeń |
| CN202180067894.4A CN116368141B (zh) | 2020-10-01 | 2021-09-30 | 噻二唑酮衍生物及其作为ampk激动剂用于治疗糖尿病和相关疾病的用途 |
| US18/028,192 US20230382930A1 (en) | 2020-10-01 | 2021-09-30 | Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders |
| EP21816508.2A EP4222147B1 (en) | 2020-10-01 | 2021-09-30 | Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders |
| PCT/GB2021/052535 WO2022069894A1 (en) | 2020-10-01 | 2021-09-30 | Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2015585.9A GB202015585D0 (en) | 2020-10-01 | 2020-10-01 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202015585D0 true GB202015585D0 (en) | 2020-11-18 |
Family
ID=73223766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2015585.9A Ceased GB202015585D0 (en) | 2020-10-01 | 2020-10-01 | New compounds |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230382930A1 (https=) |
| EP (1) | EP4222147B1 (https=) |
| JP (1) | JP7793614B2 (https=) |
| KR (1) | KR20230079163A (https=) |
| CN (1) | CN116368141B (https=) |
| AU (1) | AU2021352146A1 (https=) |
| CA (1) | CA3193947A1 (https=) |
| ES (1) | ES3018732T3 (https=) |
| GB (1) | GB202015585D0 (https=) |
| HU (1) | HUE071685T2 (https=) |
| MX (1) | MX2023003825A (https=) |
| PL (1) | PL4222147T3 (https=) |
| WO (1) | WO2022069894A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11691954B2 (en) | 2019-10-18 | 2023-07-04 | Betagenon Ab | Formulations |
| GB202112529D0 (en) * | 2021-09-02 | 2021-10-20 | Betagenon Bio Ab | New compounds |
| EP4600642A1 (en) * | 2022-10-05 | 2025-08-13 | Sawai Pharmaceutical Co., Ltd. | Method for selecting additive capable of inhibiting nitrosation reaction, and preparation prevented from generation of nitroso compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5982281B2 (ja) * | 2009-07-08 | 2016-08-31 | バルティック バイオ アーベー | 医薬として有用な化合物 |
| WO2013108026A1 (en) * | 2012-01-17 | 2013-07-25 | Baltic Bio Ab | Thiadiazolone derivatives useful in the treatment of diabetes |
| AU2018448511B2 (en) * | 2018-11-05 | 2025-07-03 | Betagenon Ab | Methods of treating diabetes in severe insulin-resistant diabetic subjects |
-
2020
- 2020-10-01 GB GBGB2015585.9A patent/GB202015585D0/en not_active Ceased
-
2021
- 2021-09-30 CN CN202180067894.4A patent/CN116368141B/zh active Active
- 2021-09-30 HU HUE21816508A patent/HUE071685T2/hu unknown
- 2021-09-30 WO PCT/GB2021/052535 patent/WO2022069894A1/en not_active Ceased
- 2021-09-30 EP EP21816508.2A patent/EP4222147B1/en active Active
- 2021-09-30 CA CA3193947A patent/CA3193947A1/en active Pending
- 2021-09-30 JP JP2023520459A patent/JP7793614B2/ja active Active
- 2021-09-30 ES ES21816508T patent/ES3018732T3/es active Active
- 2021-09-30 US US18/028,192 patent/US20230382930A1/en active Pending
- 2021-09-30 MX MX2023003825A patent/MX2023003825A/es unknown
- 2021-09-30 AU AU2021352146A patent/AU2021352146A1/en active Pending
- 2021-09-30 PL PL21816508.2T patent/PL4222147T3/pl unknown
- 2021-09-30 KR KR1020237014527A patent/KR20230079163A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3193947A1 (en) | 2022-04-07 |
| HUE071685T2 (hu) | 2025-09-28 |
| JP7793614B2 (ja) | 2026-01-05 |
| CN116368141A (zh) | 2023-06-30 |
| ES3018732T3 (en) | 2025-05-19 |
| PL4222147T3 (pl) | 2025-06-09 |
| EP4222147C0 (en) | 2025-03-19 |
| JP2023543924A (ja) | 2023-10-18 |
| EP4222147A1 (en) | 2023-08-09 |
| AU2021352146A1 (en) | 2023-06-01 |
| MX2023003825A (es) | 2023-06-06 |
| EP4222147B1 (en) | 2025-03-19 |
| WO2022069894A1 (en) | 2022-04-07 |
| KR20230079163A (ko) | 2023-06-05 |
| US20230382930A1 (en) | 2023-11-30 |
| CN116368141B (zh) | 2025-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4452937A4 (en) | CONNECTIONS | |
| GB202013721D0 (en) | New compounds | |
| GB202104038D0 (en) | New compounds | |
| GB202104039D0 (en) | New compounds | |
| GB202015585D0 (en) | New compounds | |
| GB202112529D0 (en) | New compounds | |
| GB202001564D0 (en) | Compounds | |
| GB202104033D0 (en) | New compounds | |
| ES3063655T3 (en) | Compounds | |
| GB202113583D0 (en) | New compounds | |
| GB202109946D0 (en) | New compounds | |
| GB202107406D0 (en) | New Compounds | |
| GB202104040D0 (en) | New compounds | |
| GB202101600D0 (en) | New compounds | |
| GB202101609D0 (en) | New compounds | |
| GB202101607D0 (en) | New compounds | |
| GB202101602D0 (en) | New compounds | |
| GB202101617D0 (en) | New compounds | |
| GB202101620D0 (en) | New compounds | |
| GB202101621D0 (en) | New compounds | |
| GB202101614D0 (en) | New compounds | |
| GB202101616D0 (en) | New compounds | |
| GB202012871D0 (en) | New compounds | |
| GB202009083D0 (en) | New compounds | |
| GB202008158D0 (en) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |